EVRYSDI is a Oral Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech Inc.. The primary component is Risdiplam.
Product ID | 50242-175_1316f231-2d4d-4624-a8b7-b05ac2b9456d |
NDC | 50242-175 |
Product Type | Human Prescription Drug |
Proprietary Name | EVRYSDI |
Generic Name | Risdiplam |
Dosage Form | Powder, For Solution |
Route of Administration | ORAL |
Marketing Start Date | 2020-08-07 |
Marketing Category | NDA / NDA |
Application Number | NDA213535 |
Labeler Name | Genentech Inc. |
Substance Name | RISDIPLAM |
Active Ingredient Strength | 1 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-08-07 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EVRYSDI 90622036 not registered Live/Pending |
Genentech, Inc. 2021-04-02 |
EVRYSDI 88769281 not registered Live/Pending |
Genentech, Inc. 2020-01-22 |
EVRYSDI 88350381 not registered Live/Pending |
Genentech, Inc. 2019-03-21 |